{"id":"https://openalex.org/W3208932116","doi":"https://doi.org/10.1111/acer.14729","title":"Is extended release naltrexone superior to buprenorphine\u2010naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial","display_name":"Is extended release naltrexone superior to buprenorphine\u2010naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial","publication_year":2021,"publication_date":"2021-10-26","ids":{"openalex":"https://openalex.org/W3208932116","doi":"https://doi.org/10.1111/acer.14729","mag":"3208932116","pmid":"https://pubmed.ncbi.nlm.nih.gov/34698397","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8722377"},"language":"en","primary_location":{"id":"doi:10.1111/acer.14729","doi":"https://doi.org/10.1111/acer.14729","is_oa":false,"landing_page_url":"https://doi.org/10.1111/acer.14729","pdf_url":null,"source":{"id":"https://openalex.org/S115510430","display_name":"Alcoholism Clinical and Experimental Research","issn_l":"0145-6008","issn":["0145-6008","1530-0277","2993-7175"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alcoholism: Clinical and Experimental Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8722377","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087899369","display_name":"John D. Roache","orcid":"https://orcid.org/0000-0002-7010-8119","observed_orcids":["https://orcid.org/0000-0002-7010-8119"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John D. Roache","raw_affiliation_strings":["Division of Alcohol & Drug Addiction Department of Psychiatry & Behavioral Sciences University of Texas Health Science Center San Antonio Texas USA"],"raw_orcid":"https://orcid.org/0000-0002-7010-8119","affiliations":[{"raw_affiliation_string":"Division of Alcohol & Drug Addiction Department of Psychiatry & Behavioral Sciences University of Texas Health Science Center San Antonio Texas USA","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079969867","display_name":"Martina Pavlicov\u00e1","orcid":"https://orcid.org/0000-0003-4400-4102","observed_orcids":["https://orcid.org/0000-0003-4400-4102"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martina Pavlicova","raw_affiliation_strings":["Biostatistics Department, Mailman School of Public Health, Columbia University, New York City, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics Department, Mailman School of Public Health, Columbia University, New York City, New York, USA","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016262149","display_name":"Aimee N. C. Campbell","orcid":"https://orcid.org/0000-0003-4247-9980","observed_orcids":["https://orcid.org/0000-0003-4247-9980"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aimee Campbell","raw_affiliation_strings":["Division on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center and New York State Psychiatric Institute, New York City, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division on Substance Use Disorders, Department of Psychiatry, Columbia University Irving Medical Center and New York State Psychiatric Institute, New York City, New York, USA","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4388891851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086344811","display_name":"Tse-Hwei J. Choo","orcid":"https://orcid.org/0000-0001-5068-9799","observed_orcids":["https://orcid.org/0000-0001-5068-9799"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tse\u2010Hwei Choo","raw_affiliation_strings":["Mental Health Data Science, Department of Psychiatry, Columbia University, New York City, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mental Health Data Science, Department of Psychiatry, Columbia University, New York City, New York, USA","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108376931","display_name":"Michelle Peavy","orcid":"https://orcid.org/0000-0002-6857-8410","observed_orcids":["https://orcid.org/0000-0002-6857-8410"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle Peavy","raw_affiliation_strings":["Evergreen Treatment Services, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evergreen Treatment Services, Seattle, Washington","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053541541","display_name":"Andrea S. Kermack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]},{"id":"https://openalex.org/I1335289525","display_name":"Montefiore Medical Center","ror":"https://ror.org/044ntvm43","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335289525","https://openalex.org/I19772626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea S. Kermack","raw_affiliation_strings":["Division of Substance Abuse, Departments of Internal Medicine and Psychiatry and Behavioral Sciences, Montefiore Medical Center, Albert Einstein College of Medicine, New York City, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Substance Abuse, Departments of Internal Medicine and Psychiatry and Behavioral Sciences, Montefiore Medical Center, Albert Einstein College of Medicine, New York City, New York, USA","institution_ids":["https://openalex.org/I129975664","https://openalex.org/I1335289525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073707428","display_name":"Edward V. Nunes","orcid":"https://orcid.org/0000-0002-2055-3425","observed_orcids":["https://orcid.org/0000-0002-2055-3425"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward V. Nunes","raw_affiliation_strings":["Columbia University Irving Medical Center and New York State Psychiatric Institute, New York City, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University Irving Medical Center and New York State Psychiatric Institute, New York City, New York, USA","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4388891851"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071920736","display_name":"John Rotrosen","orcid":"https://orcid.org/0000-0002-0283-5576","observed_orcids":["https://orcid.org/0000-0002-0283-5576"]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Rotrosen","raw_affiliation_strings":["New York University Grossman School of Medicine, New York City, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University Grossman School of Medicine, New York City, New York, USA","institution_ids":["https://openalex.org/I57206974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5087899369"],"corresponding_institution_ids":["https://openalex.org/I165951966"],"apc_list":{"value":3465,"currency":"USD","value_usd":3465},"apc_paid":null,"fwci":0.8997,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.73121185,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"45","issue":"12","first_page":"2569","last_page":"2578"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.6323000192642212,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.6323000192642212,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.36550000309944153,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11860","display_name":"HIV, Drug Use, Sexual Risk","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine-naloxone","display_name":"buprenorphine/naloxone","score":1.0},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9950000047683716},{"id":"https://openalex.org/keywords/alcoholism","display_name":"alcoholism","score":0.699999988079071},{"id":"https://openalex.org/keywords/heavy-drinking","display_name":"heavy drinking","score":0.7549999952316284},{"id":"https://openalex.org/keywords/alcohol-consumption","display_name":"alcohol consumption","score":0.4440000057220459},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.44699999690055847},{"id":"https://openalex.org/keywords/opioid-agonists","display_name":"opioid agonists","score":0.9309999942779541},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.42899999022483826}],"concepts":[{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.9489281177520752},{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.8226046562194824},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.7810262441635132},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.7559130191802979},{"id":"https://openalex.org/C2910878864","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Narcotic antagonists","level":5,"score":0.5740209817886353},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5700145959854126},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5479854345321655},{"id":"https://openalex.org/C3019590667","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Narcotic antagonist","level":5,"score":0.5098689794540405},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.47093287110328674},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.37459272146224976},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14614209532737732},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069479","descriptor_name":"Buprenorphine, Naloxone Drug Combination","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010045","descriptor_name":"Outpatients","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/acer.14729","doi":"https://doi.org/10.1111/acer.14729","is_oa":false,"landing_page_url":"https://doi.org/10.1111/acer.14729","pdf_url":null,"source":{"id":"https://openalex.org/S115510430","display_name":"Alcoholism Clinical and Experimental Research","issn_l":"0145-6008","issn":["0145-6008","1530-0277","2993-7175"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alcoholism: Clinical and Experimental Research","raw_type":"journal-article"},{"id":"pmid:34698397","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34698397","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alcoholism, clinical and experimental research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8722377","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8722377","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Alcohol Clin Exp Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:8722377","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8722377","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Alcohol Clin Exp Res","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G114177176","display_name":"Florida Node Alliance of the Drug Abuse Clinic Trials Network","funder_award_id":"U10DA013720","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G138054407","display_name":null,"funder_award_id":"UG1/U10DA013714","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G1451639521","display_name":"Clinical Trials Network: Greater New York Node","funder_award_id":"U10DA013035","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G1627524083","display_name":"Drug Abuse Treatment Development and Research Mentoring","funder_award_id":"K24DA022412","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G1842581027","display_name":"NIDA Clinical Trials Network - New York Node","funder_award_id":"U10DA013046","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G2151805093","display_name":null,"funder_award_id":"UG1/U10DA013035","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G2224778681","display_name":"Clinical Trials Network, Ohio Valley Node U10DA013732","funder_award_id":"U10DA013732","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G3879315323","display_name":null,"funder_award_id":"UG1/U10DA015831","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G4867824689","display_name":"The National Drug Abuse Treatment Clinical Trials Network","funder_award_id":"U10DA013045","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5112719437","display_name":"Clinical Trials Network: Pacific Northwest Node","funder_award_id":"U10DA013714","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5727918891","display_name":"The National Drug Abuse Treatment Clinical Trials Network (U10)","funder_award_id":"U10DA015831","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G6415011113","display_name":"Clinical Trials Network: Southwest Node","funder_award_id":"U10DA015833","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G6429698798","display_name":null,"funder_award_id":"HHSN271201500065C","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G6752561216","display_name":null,"funder_award_id":"UG1/U10DA013034","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G704638895","display_name":"Clinical Trials Network Mid-Atlantic Collaborative Group","funder_award_id":"5u10da013034-15","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G7063556272","display_name":null,"funder_award_id":"UG1/U10DA013720","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G779219409","display_name":null,"funder_award_id":"HHSN271201200017C","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G854964702","display_name":null,"funder_award_id":"UG1/U10DA013732","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000880887","display_name":"NIDA Clinical Trials Network: New York Node - Renewal-GY24","funder_award_id":"UG1DA013035","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000909821","display_name":"Clinical Trials Network: Pacific Northwest Node","funder_award_id":"UG1DA013714","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W1623733931","https://openalex.org/W1770934634","https://openalex.org/W1974741209","https://openalex.org/W1990391721","https://openalex.org/W2002105418","https://openalex.org/W2010906830","https://openalex.org/W2032105912","https://openalex.org/W2036259797","https://openalex.org/W2048849975","https://openalex.org/W2055782614","https://openalex.org/W2056965785","https://openalex.org/W2066840940","https://openalex.org/W2076078537","https://openalex.org/W2076293542","https://openalex.org/W2077358351","https://openalex.org/W2083060011","https://openalex.org/W2093559862","https://openalex.org/W2101372918","https://openalex.org/W2103050138","https://openalex.org/W2104538950","https://openalex.org/W2112963881","https://openalex.org/W2116745456","https://openalex.org/W2119681201","https://openalex.org/W2120690735","https://openalex.org/W2132974770","https://openalex.org/W2136222996","https://openalex.org/W2138742021","https://openalex.org/W2140407904","https://openalex.org/W2143190301","https://openalex.org/W2158010305","https://openalex.org/W2164678034","https://openalex.org/W2168472107","https://openalex.org/W2327966153","https://openalex.org/W2342885448","https://openalex.org/W2413464033","https://openalex.org/W2512537769","https://openalex.org/W2517268165","https://openalex.org/W2517652980","https://openalex.org/W2560157258","https://openalex.org/W2565728627","https://openalex.org/W2567850197","https://openalex.org/W2626583042","https://openalex.org/W2747986097","https://openalex.org/W2768214444","https://openalex.org/W2805243591","https://openalex.org/W2890263000","https://openalex.org/W2902655755","https://openalex.org/W2945782078","https://openalex.org/W2995330948","https://openalex.org/W3008003623","https://openalex.org/W4245487921"],"related_works":["https://openalex.org/W2768214444","https://openalex.org/W7204255083","https://openalex.org/W3164392145","https://openalex.org/W4238238277","https://openalex.org/W1978554514","https://openalex.org/W2517652980","https://openalex.org/W3110775636","https://openalex.org/W3199716029","https://openalex.org/W4387783690","https://openalex.org/W3118218653"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,314],"comparative":[2],"effectiveness":[3],"of":[4,61,65,116,125,168,178,185,212,225,227,233,236,280,292,321],"extended-release":[5],"naltrexone":[6],"versus":[7],"buprenorphine-naloxone":[8],"for":[9,189,334],"opioid":[10,37,43],"relapse":[11,38],"prevention":[12],"(X:BOT)":[13],"trial":[14,330],"showed":[15],"that":[16,301,304],"following":[17],"induction,":[18],"treatment":[19,70,143,291,333],"with":[20,42,93,195,230],"the":[21,62,103,113,136,169,217,246,257,278,302],"sublingual":[22],"agonist":[23,296],"(buprenorphine-naloxone,":[24],"BUP-NX)":[25],"or":[26,88,276,324],"injected":[27],"antagonist":[28,298],"(extended":[29],"release":[30],"naltrexone,":[31],"XR-NTX)":[32],"produced":[33],"similar":[34],"reductions":[35],"in":[36,39,51,85,91,288,328],"injection":[40],"users":[41],"use":[44,53],"disorder":[45,54],"(OUD).":[46],"Because":[47],"XR-NTX":[48,74,258,305],"reduces":[49],"drinking":[50,87,90,118,121,146,191,214,229,254,272,289,326],"alcohol":[52],"(AUD),":[55],"we":[56],"conducted":[57],"a":[58,129,186,231],"secondary":[59],"analysis":[60,133],"X:BOT":[63,329],"sample":[64,170],"patients":[66,92],"successfully":[67],"inducted":[68],"onto":[69],"to":[71,80,111,134,138,149,152,216,309],"determine":[72],"whether":[73],"(n":[75,82,165,175],"=":[76,83,166,176,261],"204)":[77],"was":[78,109,284,311],"superior":[79,308],"BUP-NX":[81,247,310],"270)":[84],"reducing":[86],"heavy":[89,120,213,325],"OUD.":[94,335],"METHODS:":[95],"Standard":[96],"drink":[97],"units":[98],"consumed":[99],"were":[100,160,180,265],"measured":[101],"using":[102,294],"Timeline":[104],"Follow-back":[105],"method.":[106],"Mixed-models":[107],"regression":[108],"used":[110,128],"examine":[112,135],"monthly":[114],"frequency":[115],"any":[117,228],"and":[119,173,297],"over":[122],"6":[123],"months":[124],"treatment.":[126,183,281],"We":[127],"proportional":[130],"hazard":[131],"survival":[132],"time":[137],"first":[139],"drink.":[140],"RESULTS:":[141],"Both":[142],"groups":[144,159],"reduced":[145],"from":[147],"baseline":[148],"posttreatment":[150],"(small":[151],"medium":[153],"effect),":[154],"but":[155,206],"no":[156,266],"differences":[157,270],"between":[158],"detected.":[161],"However,":[162,219],"only":[163,223,234],"29%":[164],"136)":[167],"had":[171],"AUD":[172,197,323],"19%":[174],"26/136)":[177],"those":[179],"abstinent":[181],"before":[182],"Analysis":[184],"subsample":[187,221],"enriched":[188],"possible":[190],"included":[192],"136":[193],"individuals":[194],"an":[196,285],"diagnosis":[198],"plus":[199],"43":[200],"who":[201],"did":[202],"not":[203,312],"have":[204],"AUD,":[205],"reported":[207,222,249],"at":[208,244,277],"least":[209],"one":[210],"day":[211,255],"prior":[215],"study.":[218],"this":[220,242],"32%":[224],"days":[226,237],"median":[232],"13%":[235],"designated":[238],"as":[239],"\"heavy.\"":[240],"Within":[241],"subsample,":[243],"baseline,":[245],"group":[248,259,269],"more":[250],"mean":[251],"drinks":[252],"per":[253],"than":[256],"(p":[260],"0.03);":[262],"however,":[263],"there":[264],"other":[267],"significant":[268],"on":[271],"observed":[273,327],"before,":[274],"during,":[275],"end":[279],"CONCLUSIONS:":[282],"There":[283],"overall":[286],"reduction":[287],"during":[290],"OUD":[293],"both":[295],"medications,":[299],"so":[300],"hypothesis":[303],"would":[306],"be":[307],"supported.":[313],"study":[315],"is":[316],"limited":[317],"by":[318],"low":[319],"levels":[320],"comorbid":[322],"participants":[331],"seeking":[332]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-11-08T00:00:00"}